Published on Apr 16, 2026
Health and safety leadership in the pharmaceutical industry has never been more critical. Pharmaceutical manufacturing combines complex processes, hazardous substances, strict regulatory requirements, and constant operational change. In this environment, effective safety leadership is essential to protect employees, ensure product integrity, and maintain business continuity.
Too often, health and safety is viewed as the responsibility of specialist EHS teams or those directly involved in production engineering. In reality, safety outcomes are shaped by leadership at every level. Managers across operations, quality, R&D, engineering and corporate functions influence safety culture through their decisions, priorities and behaviours. Safety is not just a system issue - it is a leadership issue.
Safety leadership and safety culture in pharma
Safety leadership is best understood as a social process: enabling people to work together safely to achieve operational goals. In pharmaceutical manufacturing, where pressure to deliver, scale and innovate is constant, leaders play a decisive role in balancing performance and risk.
A strong safety culture - often described as “the way we do things around here” - does not develop by accident. It is reinforced daily through leadership behaviour. When leaders visibly prioritise safety, communicate openly about risk, and respond constructively to incidents, they create an environment where safe behaviour becomes the norm rather than the exception.
Safety management vs safety leadership
Understanding the distinction between safety management and safety leadership is critical. Safety management focuses on systems, procedures, monitoring and resources. Safety leadership, by contrast, sets direction, establishes priorities and ensures accountability.
While safety tasks can be delegated, accountability cannot. Leaders remain responsible for ensuring that safety-critical roles are filled by competent individuals with the right skills, knowledge and capacity. In pharmaceutical operations, where process safety and change management are vital, weak leadership oversight can quickly undermine even well-designed systems.
Lessons from major industrial safety failures
Historical safety failures offer powerful lessons for pharmaceutical leaders. Catastrophic incidents such as the Flixborough chemical plant explosion and the Piper Alpha oil platform disaster were not caused by single technical faults. They resulted from leadership failures: poor communication, unmanaged change, unclear responsibilities, and assumptions that went unchallenged.
Although these events occurred outside the pharmaceutical sector, the underlying causes - leadership blind spots, system weaknesses and cultural failures - are directly relevant to pharma manufacturing and laboratory environments.
Human error and leadership response
Human error is an unavoidable part of complex systems. Errors such as slips, lapses and mistakes occur even among experienced professionals. Effective health and safety leadership recognises this reality and focuses on learning rather than blame.
Leaders who understand human factors can distinguish between error and violation, respond proportionately, and address the system conditions that shape behaviour. In pharmaceutical environments, where precision and compliance are critical, this approach strengthens both safety performance and employee trust.
Managing assumptions and emerging risks
Unexamined assumptions are a significant source of risk in safety-critical industries. Assumptions about how processes operate, how risks are controlled, or how people will behave can quietly erode safety margins. Leaders must actively question and validate these assumptions, particularly during periods of change.
Pharmaceutical leaders must also manage both everyday operational risks and extreme events. Some threats are unpredictable ‘Black Swans’, while others are obvious but under-addressed ‘Grey Rhinos’. Effective safety leadership focuses on preparedness and resilience, rather than prediction alone.
Building resilient safety leadership
Scenario planning, crisis simulations and tabletop exercises help leaders practice decision-making under pressure and identify weaknesses before real incidents occur. These tools reinforce communication, role clarity and calm leadership - capabilities that are essential in pharmaceutical risk management.
Conclusion
Health and safety leadership in the pharmaceutical industry goes far beyond regulatory compliance. It is about influencing behaviour, understanding human error, managing risk intelligently, and ensuring safety systems remain effective as processes evolve. In a sector where failures can have serious consequences for employees, patients and organisations, strong safety leadership is not optional - it is a core leadership responsibility.
To understand more about health & safety leadership specifically for the pharma sector, join our expert trainer, Andy Farrall, for his one-day Mastering Health & Safety Leadership in the Pharmaceutical Industry course.
Andy Farrall is both a Fellow of the International Institute for Risk & Safety Management (FIIRSM) and a Chartered Member of IOSH (CMIOSH). He is also accredited as a safety consultant on the UK OSHCR consultants’ register.
With some 15 years’ experience in safety management, he has built a reputation as an international speaker on safety matters, having been invited on a number of occasions to address professional groups in the Middle East on topics such as accident management and the management of blame.
In addition, he was invited to collaborate on a project with the Irish Ambulance Service College in Dublin. At their request he designed, and then presented, specialist courses on critical decision making for senior operational officers and paramedics within the Irish National Ambulance Service.
And he was especially pleased to be invited by the European Society for Occupational Safety & Health (ESOSH) to address their IXth International Scientific & Practical Conference: “Occupational Safety 2022 – European Integration and Innovation”.
His presentation for their conference was entitled “Critical thinking: decision-making in times of crisis”.
The seminar, hosted online from Warsaw, was specifically set up as a platform to provide technical support to both the Ukraine Government and to key Ukraine organisations such as trade unions and the Social Security and Social Insurance Fund of Ukraine.
As well as this course, Andy has also partnered with IPI Academy to develop and present one-day webinars for the pharmaceutical sector on Managing Human Error: A Strategic Approach for Pharmaceutical Managers and Crisis Management from a Tactical Operations Perspective: A Practical Guide for Managers in the Pharmaceutical Sector
Published on Apr 16, 2026 by Andy Farrall